Full Program Released for the 10th Annual Precision Farming Dealer Summit

Oct 10, 2024

Precision Farming Dealer has announced the full speaker and session lineup confirmed for the 2025 Precision Farming Dealer Summit that is 100% focused on equipping your company to run a more profitable precision farming business. Download the just-released program now.

To be held at the Louisville Marriott Downtown Hotel in Louisville, Ky., on January 6-7, the 2025 Precision Farming Dealer Summit will explore precision farming business development topics of critical importance to top-level decision makers. Discussing the 2025 event, Precision Farming Dealer technology editor Noah Newman says despite the challenges of the last few years, dealers need to continue adapting their precision business to create opportunity out of adversity.

"As drones, autonomy and machine learning gain momentum, dealers need to maneuver their business plans to ensure they are managing their precision business forward into the future,” he says. “We've built this year's program to provide valuable insight from all sides of the industry — dealers, farmers, OEMs and more — that will equip our attendees with actionable takeaways to improve their precision business in 2025 and beyond."

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.